Trial Profile
Renoprotective Effect of ALiskiren in Japanese Hypertensive Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Angiotensin receptor antagonists
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms REAL
- 16 Apr 2011 New trial record